Persistent URL of this record https://hdl.handle.net/1887/3565035
In Collections
This item can be found in the following collections:
Nivolumab Plus Ipilimumab Should Be the Standard of Care for First-Line Unresectable Epithelioid Mesothelioma
- All authors
- Baas, P.
- Date
- 2021-12-17
- Title of host publication
- Journal of Thoracic Oncology
- Volume
- 17
- Issue
- 1
- Pages
- 30 - 33